blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3243510

EP3243510 - SULFONAMIDE PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.07.2023
Database last updated on 12.07.2024
FormerThe patent has been granted
Status updated on  29.07.2022
FormerGrant of patent is intended
Status updated on  21.04.2022
FormerExamination is in progress
Status updated on  31.07.2020
FormerRequest for examination was made
Status updated on  13.10.2017
FormerThe international publication has been made
Status updated on  05.07.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): MC		published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area, Tianjin 300457 / CN
[2017/46]
Inventor(s)01 / WU, Yi Juang
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
02 / YAO, Xiaoqing
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
03 / SUN, Changhai
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
04 / TIAN, Li
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
05 / ZHAO, Xinying
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
06 / HAN, Zhidong
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
07 / LIN, Chuangyu
4-C-203
Teda SME Park
203 Huanghai Road
Binhai New Area
Tianjin 300457 / CN
 [2017/46]
Representative(s)Lermer, Christoph
Nove Haus - Design Offices
Luise-Ullrich-Straße 14
80636 München / DE
[N/P]
Former [2017/46]Lermer, Christoph
LermerRaible Patent- u. Rechtsanwalts PartGmbB
Lessingstrasse 6
80336 München / DE
Application number, filing date16734885.304.01.2016
[2017/46]
WO2016CN70015
Priority number, dateCN2015100599506.01.2015         Original published format: CN201510005995
[2017/46]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016110225
Date:14.07.2016
Language:ZH
[2016/28]
Type: A1 Application with search report 
No.:EP3243510
Date:15.11.2017
Language:EN
[2017/46]
Type: B1 Patent specification 
No.:EP3243510
Date:31.08.2022
Language:EN
[2022/35]
Search report(s)International search report - published on:CN14.07.2016
(Supplementary) European search report - dispatched on:EP05.07.2018
ClassificationIPC:A61K31/18, A61K47/34, A61K9/08, A61P35/00
[2018/31]
CPC:
A61K31/18 (EP,KR,RU,US); A61K47/10 (KR,RU,US); A61K47/12 (KR,RU,US);
A61K47/20 (US); A61K47/34 (EP,US); A61K9/0019 (EP,KR,US);
A61K9/08 (EP,KR,RU,US); A61P35/00 (EP,RU,US) (-)
Former IPC [2017/46]A61K31/18, A61K9/08, A61K47/12, A61K47/10, A61P35/00, A61P35/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/46]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PHARMAZEUTISCHE SULFONAMID-ZUSAMMENSETZUNG[2017/46]
English:SULFONAMIDE PHARMACEUTICAL COMPOSITION[2017/46]
French:COMPOSITION PHARMACEUTIQUE DE SULFONAMIDE[2017/46]
Entry into regional phase04.07.2017Translation filed 
28.07.2017National basic fee paid 
28.07.2017Search fee paid 
28.07.2017Designation fee(s) paid 
28.07.2017Examination fee paid 
Examination procedure04.07.2017Date on which the examining division has become responsible
28.07.2017Examination requested  [2017/46]
11.01.2019Amendment by applicant (claims and/or description)
30.07.2020Despatch of a communication from the examining division (Time limit: M02)
24.09.2020Reply to a communication from the examining division
22.04.2022Communication of intention to grant the patent
26.07.2022Fee for grant paid
26.07.2022Fee for publishing/printing paid
26.07.2022Receipt of the translation of the claim(s)
Opposition(s)01.06.2023No opposition filed within time limit [2023/32]
Fees paidRenewal fee
24.01.2018Renewal fee patent year 03
24.01.2019Renewal fee patent year 04
30.12.2019Renewal fee patent year 05
01.01.2021Renewal fee patent year 06
13.12.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
MC31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SI31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
IE04.01.2023
LU04.01.2023
BE31.01.2023
[2024/29]
Former [2024/08]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SI31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
IE04.01.2023
LU04.01.2023
BE31.01.2023
Former [2023/49]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SI31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
LU04.01.2023
BE31.01.2023
Former [2023/43]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SI31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
LU04.01.2023
Former [2023/37]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SI31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
Former [2023/30]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
NL31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
Former [2023/29]AL31.08.2022
AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
Former [2023/23]AT31.08.2022
CZ31.08.2022
DK31.08.2022
EE31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SK31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
Former [2023/22]AT31.08.2022
CZ31.08.2022
DK31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RO31.08.2022
RS31.08.2022
SE31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
PT02.01.2023
Former [2023/21]DK31.08.2022
ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RS31.08.2022
SE31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
Former [2023/20]ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RS31.08.2022
SE31.08.2022
SM31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
Former [2023/12]ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RS31.08.2022
SE31.08.2022
NO30.11.2022
GR01.12.2022
IS31.12.2022
Former [2023/11]ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
PL31.08.2022
RS31.08.2022
SE31.08.2022
NO30.11.2022
GR01.12.2022
Former [2023/10]ES31.08.2022
FI31.08.2022
HR31.08.2022
LT31.08.2022
LV31.08.2022
RS31.08.2022
SE31.08.2022
NO30.11.2022
GR01.12.2022
Former [2023/09]ES31.08.2022
FI31.08.2022
LT31.08.2022
LV31.08.2022
RS31.08.2022
SE31.08.2022
NO30.11.2022
Former [2023/08]ES31.08.2022
FI31.08.2022
LT31.08.2022
RS31.08.2022
SE31.08.2022
NO30.11.2022
Documents cited:Search[YD]CN1073415C  (WU YIZHUANG [CN]) [YD] 1-10 * abstract *;
 [Y]EP1498418  (ENCYSIVE PHARMACEUTICALS INC [US]) [Y] 1-10* page 55, lines 51-55; table 5 *
International search[XY]US5891454  (WU JOHN Y J [US]) [X] 1-9 * , embodiments I, II and VIII, embodiments I, II and VIII * [Y] 10;
 [XY]CN1511032  (PTS INTERNATIONAL INC [US]) [X] 1-9 * , claims 1-2, and description, page 14, table 1, claims 1-2, and description, page 14, table 1 * [Y] 10;
 [Y]CN102389410  (HUANG MANXIANG) [Y] 10* , description, page 5, embodiment 3 *;
 [PX]CN104473914  (TIANJIN HONGRI JIANDAKANG PHARMACEUTICAL CO LTD) [PX] 1-10 * , claims 1-10 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.